A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease
Aging · 2023
DOI: 10.18632/aging.204611 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Aging, 2023. Verfasst von Jun Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, First Clinical Medical College, Hangzhou, Zhejiang 310000, China. Hauptthemen laut MEDLINE: Prolyl-Hydroxylase Inhibitors, Renal Insufficiency, Chronic, Hypertension. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Chinese Medical University, First Clinical Medical College, Hangzhou, Zhejiang 310000, China.
- Department of Pharmaceutical, Lishui Municipal Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang 323000, China.
- Department of Nephrology, Lishui Municipal Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang 323000, China.
- Department of Pharmaceutical, Zhejiang Provincial People’s Hospital, Hangzhou, Zhejiang 310000, China.
Zitieren
APA
Chen, J., Shou, X., Xu, Y., Jin, L., Zhu, C., Ye, X., Mei, Z., & Chen, P. (2023). A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease. Aging. https://doi.org/10.18632/aging.204611
Vancouver
Chen J, Shou X, Xu Y, Jin L, Zhu C, Ye X, et al. A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease. Aging. 2023. doi:10.18632/aging.204611
BibTeX
@article{Chen2023,
author = {Chen, Jun and Shou, Xinyang and Xu, Yanyan and Jin, Lie and Zhu, Chaoyong and Ye, Xiaolan and Mei, Ziwei and Chen, Peipei},
title = {A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204611}
}
EUVIMED